MediPharm Labs Sets Date to Report Third Quarter 2026 Financial Results
Globe Newswire•06/11/2026•18:00 ET
2
Key Highlights
- ➤Q3 2026 results scheduled for release before markets open November 12
- ➤Conference call and webcast set for 10:00 a.m. Eastern on November 12
- ➤MediPharm Labs holds TSX ticker LABS and OTCQB ticker MEDIF
TORONTO, Nov. 06, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, will release its third quarter financial results for the three and nine months ended September 30(th), 2026, before markets open on Thursday, November 12(th), 2026.
MediPharm Labs executive management team will also host a conference call and webcast on November 12(th), 2026, at 10:00 a.m. (Eastern time) to discuss the Company’s financial results.
Get started
Create a free account to read the full story.